Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.55B |
| 2 |
Gilead Sciences
GILD
|
+$968M |
| 3 |
CME Group
CME
|
+$953M |
| 4 |
Broadcom
AVGO
|
+$809M |
| 5 |
TE Connectivity
TEL
|
+$753M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$2.6B |
| 2 |
CSX Corp
CSX
|
+$2.44B |
| 3 |
Amgen
AMGN
|
+$2.27B |
| 4 |
AbbVie
ABBV
|
+$1.67B |
| 5 |
Netflix
NFLX
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.59% |
| 2 | Technology | 15.06% |
| 3 | Communication Services | 14.47% |
| 4 | Consumer Discretionary | 13.12% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEE.PRR
301
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $79.7M | 0.02% |
1,400,000
| – | – |
|
302
State Street
STT
$52.2B
| $79.7M | 0.02% |
951,030
-3
| -0% | -$264 |
|
303
MakeMyTrip
MMYT
$5.67B
| $79.7M | 0.02% |
+2,902,569
| New | +$92.6M |
|
304
Encompass Health
EHC
$12.3B
| $79.5M | 0.02% |
1,282,643
| – | – |
|
|
NCNA
305
NuCana
NCNA
$5.95M
| $79M | 0.02% |
634
| – | – |
|
306
NMI Holdings
NMIH
$3.38B
| $78.8M | 0.02% |
3,481,202
| – | – |
|
307
Matsons
MATX
$6.41B
| $74.6M | 0.02% |
1,882,000
| – | – |
|
308
Akamai
AKAM
$17.6B
| $73.5M | 0.02% |
1,005,352
-386,372
| -28% | -$29M |
|
309
Guidewire Software
GWRE
$14.4B
| $71.5M | 0.02% |
707,900
+60,000
| +9% | +$5.77M |
|
|
EIGI
310
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $71.5M | 0.02% |
8,123,677
+224,100
| +3% | +$2.13M |
|
311
Bristol-Myers Squibb
BMY
$130B
| $69.8M | 0.02% |
1,125,000
| – | – |
|
312
Toll Brothers
TOL
$13.9B
| $69.5M | 0.02% |
2,105,000
| – | – |
|
|
EGN
313
DELISTED
Energen
EGN
| $68M | 0.02% |
+789,000
| New | +$60.1M |
|
|
IMGN
314
DELISTED
Immunogen Inc
IMGN
| $67.2M | 0.02% |
7,095,570
-2,335,430
| -25% | -$22.5M |
|
315
MGIC Investment
MTG
$6.29B
| $66.5M | 0.02% |
5,000,000
| – | – |
|
316
Texas Capital Bancshares
TCBI
$4.38B
| $65.5M | 0.02% |
793,000
-1,176,532
| -60% | -$107M |
|
317
Royal Caribbean
RCL
$82.4B
| $65M | 0.02% |
500,000
| – | – |
|
|
DOCU
318
DocuSign
DOCU
$11.1B
| $64.7M | 0.02% |
1,257,900
+556,800
| +79% | +$31.6M |
|
319
Avient
AVNT
$4.16B
| $63.8M | 0.02% |
1,459,000
-100,000
| -6% | -$4.37M |
|
320
Alexandria Real Estate Equities
ARE
$8.27B
| $61.7M | 0.02% |
490,579
| – | – |
|
321
Williams Companies
WMB
$90.1B
| $61.2M | 0.02% |
2,252,259
+860,259
| +62% | +$25M |
|
|
BLD
322
DELISTED
TopBuild
BLD
| $59.7M | 0.02% |
+1,050,000
| New | +$74.8M |
|
323
Cognex
CGNX
$10.2B
| $58.6M | 0.02% |
1,050,000
| – | – |
|
324
Digital Realty Trust
DLR
$72.9B
| $57.8M | 0.02% |
514,022
+173,004
| +51% | +$20.7M |
|
325
Generac Holdings
GNRC
$13.1B
| $56.9M | 0.02% |
1,009,500
-220,000
| -18% | -$12.1M |
|
Similar funds
Capital Research Global Investors's Q3 2018 Portfolio in Review
As of Q3 2018, Capital Research Global Investors held 485 positions worth $344B, down 6% from $366B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors withdrew a net $39.8B in Q3 2018, closing 49 positions and reducing 220 holdings. Its most notable exit was Praxair Inc, an estimated $1.17B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Capital Research Global Investors opened a new position in TE Connectivity worth $720M.
- Capital Research Global Investors's largest Q3 2018 buy was TE Connectivity: 8,189,669 shares worth $720M.
- Capital Research Global Investors added most to Meta Platforms (Facebook) in Q3 2018, an estimated $4.55B increase.
- Capital Research Global Investors's biggest Q3 2018 reduction was Wells Fargo, cutting an estimated $2.6B.
- Capital Research Global Investors fully exited Praxair Inc in Q3 2018, selling an estimated $1.17B.
- Capital Research Global Investors's ten largest holdings make up 29% of its $344B portfolio in Q3 2018.
- Capital Research Global Investors opened 45 new positions and closed 49 in Q3 2018.
- Capital Research Global Investors's portfolio value fell 6% quarter-over-quarter to $344B.
Based on Capital Research Global Investors's 13F filing for Q3 2018, filed 14 Nov 2018.